DrugCite
Search

HUMALOG MIX

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Humalog Mix Adverse Events Reported to the FDA Over Time

How are Humalog Mix adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Humalog Mix, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Humalog Mix is flagged as the suspect drug causing the adverse event.

Most Common Humalog Mix Adverse Events Reported to the FDA

What are the most common Humalog Mix adverse events reported to the FDA?

Blood Glucose Increased
810 (6.57%)
Blood Glucose Decreased
313 (2.54%)
Hypoglycaemia
272 (2.21%)
Fall
213 (1.73%)
Hyperglycaemia
203 (1.65%)
Drug Ineffective
162 (1.31%)
Myocardial Infarction
139 (1.13%)
Malaise
136 (1.1%)
Hospitalisation
135 (1.09%)
Incorrect Dose Administered
129 (1.05%)
Asthenia
124 (1.01%)
Show More Show More
Cerebrovascular Accident
124 (1.01%)
Drug Dispensing Error
118 (.96%)
Visual Acuity Reduced
113 (.92%)
Blindness
112 (.91%)
Dyspnoea
109 (.88%)
Blood Glucose Fluctuation
108 (.88%)
Death
100 (.81%)
Loss Of Consciousness
94 (.76%)
Dizziness
93 (.75%)
Hypertension
88 (.71%)
Pneumonia
88 (.71%)
Wrong Drug Administered
86 (.7%)
Diabetes Mellitus Inadequate Contro...
85 (.69%)
Feeling Abnormal
85 (.69%)
Tremor
84 (.68%)
Cataract
81 (.66%)
Pain In Extremity
78 (.63%)
Vomiting
75 (.61%)
Cardiac Disorder
74 (.6%)
Hypoglycaemic Unconsciousness
74 (.6%)
Drug Dose Omission
72 (.58%)
Headache
72 (.58%)
Injection Site Pain
72 (.58%)
Fatigue
69 (.56%)
Hypoaesthesia
69 (.56%)
Hyperhidrosis
68 (.55%)
Syncope
66 (.54%)
Visual Impairment
66 (.54%)
Memory Impairment
61 (.49%)
Drug Exposure During Pregnancy
59 (.48%)
Oedema Peripheral
56 (.45%)
Weight Decreased
54 (.44%)
Cardiac Failure Congestive
53 (.43%)
Pain
53 (.43%)
Blood Glucose Abnormal
52 (.42%)
Glycosylated Haemoglobin Increased
51 (.41%)
Nausea
51 (.41%)
Convulsion
50 (.41%)
Eye Haemorrhage
49 (.4%)
Blindness Unilateral
48 (.39%)
Chest Pain
47 (.38%)
Renal Failure
47 (.38%)
Cardiac Failure
46 (.37%)
Neuropathy Peripheral
46 (.37%)
Mobility Decreased
45 (.36%)
Gait Disturbance
43 (.35%)
Thrombosis
41 (.33%)
Vision Blurred
41 (.33%)
Anxiety
40 (.32%)
Back Pain
40 (.32%)
Wrong Technique In Drug Usage Proce...
40 (.32%)
Weight Increased
38 (.31%)
Pyrexia
37 (.3%)
Road Traffic Accident
37 (.3%)
Arthritis
36 (.29%)
Medication Error
36 (.29%)
Nasopharyngitis
36 (.29%)
Confusional State
35 (.28%)
Eye Disorder
35 (.28%)
Hypophagia
34 (.28%)
Coma
33 (.27%)
Renal Disorder
33 (.27%)
Abdominal Pain
32 (.26%)
Decreased Appetite
32 (.26%)
Expired Drug Administered
32 (.26%)
Urinary Tract Infection
32 (.26%)
Diarrhoea
31 (.25%)
Surgery
30 (.24%)
Transient Ischaemic Attack
30 (.24%)
Amnesia
29 (.24%)
Diabetic Retinopathy
29 (.24%)
Knee Arthroplasty
29 (.24%)
Poor Quality Drug Administered
29 (.24%)
Pruritus
29 (.24%)
Diabetic Ketoacidosis
28 (.23%)
Lung Neoplasm Malignant
28 (.23%)
Injection Site Haematoma
27 (.22%)
Injection Site Haemorrhage
27 (.22%)
Drug Hypersensitivity
26 (.21%)
Drug Prescribing Error
26 (.21%)
Hip Fracture
26 (.21%)
Hypoglycaemic Coma
26 (.21%)
Infarction
26 (.21%)
Muscular Weakness
26 (.21%)
Overdose
26 (.21%)
Chest Discomfort
25 (.2%)
Contusion
25 (.2%)
Cough
25 (.2%)
Hypotension
25 (.2%)
Insomnia
25 (.2%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Humalog Mix, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Humalog Mix is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Humalog Mix

What are the most common Humalog Mix adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Humalog Mix, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Humalog Mix is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Humalog Mix According to Those Reporting Adverse Events

Why are people taking Humalog Mix, according to those reporting adverse events to the FDA?

Diabetes Mellitus
1289
Type 2 Diabetes Mellitus
578
Type 1 Diabetes Mellitus
86
Diabetes Mellitus Non-insulin-depen...
40
Gestational Diabetes
23
Diabetes Mellitus Insulin-dependent
20
Show More Show More
Blood Glucose Increased
13
Drug Use For Unknown Indication
11
Hyperglycaemia
8
Insulin-requiring Type 2 Diabetes M...
5
Blood Glucose Fluctuation
5
Product Used For Unknown Indication
5
Insulin-requiring Type Ii Diabetes ...
3
Pancreatic Disorder
2
Medication Error
2
Latent Autoimmune Diabetes In Adult...
2
Diabetes Mellitus Management
1
Blood Glucose
1
Hypoglycaemia
1

Humalog Mix Case Reports

What Humalog Mix safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Humalog Mix. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Humalog Mix.